Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, And Amphetamine Sulfate Capsule, Extended Release
Pricing Report NDC 0781-2368-01

Latest NADAC: $0.55842 per EA · Effective Sep 17, 2025 · Est. package price $55.84 (100 EA)

Current Package Pricing Information

The latest wholesale acquisition cost for Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, And Amphetamine Sulfate (NDC 0781-2368-01) is $0.55842 per EA. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Sep 17, 2025.

As a a human prescription drug provided by Sandoz Inc, this medication is distributed in a 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$0.55842
Per EA

Effective Date
Sep 17, 2025
Billable Units
100 EA
Estimated Package Price
$55.84
Data Status
As of Oct 15, 2025
C/I - Chain or Independent Pharmacy
Package NDC
Description
100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE
Pricing Methodology Explanation
The NADAC was calculated using information from the most recently completed pharmacy survey.
The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Oct 2016, the NADAC wholesale price for (NDC ) has moved within a range of $0.41729 to $3.25083 per EA. Over this 8 years and 11 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$0.4173 - $3.2508
Market Volatility
679.03% Variance
Latest Trend
2.18%

Recent NADAC Price History

DateUnit PriceUnitSourceMethodRate
Sep 17, 2025 $0.55842 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Aug 20, 2025 $0.57089 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jul 23, 2025 $0.60021 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jun 18, 2025 $0.59263 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
May 21, 2025 $0.62965 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Apr 23, 2025 $0.60523 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Mar 19, 2025 $0.70525 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Feb 19, 2025 $0.75366 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jan 22, 2025 $0.73253 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Dec 18, 2024 $0.69015 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Nov 20, 2024 $0.52976 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Oct 23, 2024 $0.72666 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic

Earlier NADAC Price History

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 4: The NADAC was carried forward from the previous file.
  • Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.


Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: September 09, 2026